VEGFA and hepatocellular carcinoma: It is well established the vasculature in HCC is abnormal; following inhibition of VEGF signalling, normalisation of neo-angiogenesis occurs, improving drug delivery and immune surveillance, as well as tumour hypoxia through vascular pruning5.